In May 2022, Italy introduced a new national transparency law designed to regulate relationships between pharmaceutical and medical device manufacturers and individuals or organizations in the healthcare sector. The law aims to increase transparency around financial relationships between manufacturers and healthcare professionals, helping to combat corruption and promote accountability.
Recent Posts
- From Chaos to Compliance: How to Coordinate Multiple Departments for Italian Sunshine Act Reporting
- Dal caos alla compliance: come coordinare più dipartimenti per il reporting dell’Italian Sunshine Act
- Vector Health presenta il primo sistema di monitoraggio basato su AI per la compliance Sanità Trasparente in Italia
- Gli integratori alimentari: tra crescita e folle deregulation
- Vector Health Unveils First AI-Powered Monitoring System for Italian Sanità Trasparente Compliance